MSD
Contact UsWorldwide
HomeProductsResearchAbout MSDCorporate Social ResponsibilityCareersLicensingSupply
 

Current Vacancies
CURRENT OPPORTUNITIES


 
Global Initiatives

It is estimated that up to 120 million people worldwide are at risk of contracting river blindness. Since 1987, Merck & Co., Inc. has committed to eliminating river blindness by donating its medicine Mectizan® free of charge.
>>Read more about Merck & Co., Inc.'s Global Initiatives
RESEARCH

It costs about £550 million and around 10-12 years to bring one medicine from discovery in a laboratory to the patient.
>>Read more about MSD's research in the UK
 

This site is intended for residents of the United Kingdom. Merck Sharp & Dohme Limited, registered in England No 820771
Privacy Policy Terms of Use Copyright © 1995-2008 Merck Sharp & Dohme Ltd Merck & CO., (USA)